Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIT plus standard of care in pediatric allergic asthma
2012-005678-76Phase 3Active
- Sponsor
- Allegria Therapeutics
- Start
- Jul 2013
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of house dust mite allergen extract in allergic asthma, house dust mite allergy, sponsored by Allegria Therapeutics. Started Jul 2013; status: active.
02
Drugs
house dust mite allergen extract
03
Conditions
allergic asthmahouse dust mite allergy
Beyond the preview
Go deeper on 2012-005678-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005678-76.